First Foundation Labs (1FL), a life sciences AI company spun out of Luma Group, announced on Tuesday a collaboration with Microsoft (NASDAQ:MSFT) to accelerate the development and enterprise deployment of its reasoning platform through Microsoft Discovery, an enterprise AI platform on Azure for accelerating scientific research, R&D, and advanced scientific computing.
1FL is building AI systems purpose-built for reasoning in life sciences, bringing together clinical, translational, and cross-domain intelligence into a unified reasoning platform.
According to 1FL Microsoft Discovery empowers life science R&D teams with capabilities across advanced knowledge reasoning and hypothesis formulation to experimental simulation and iterative learning. 1FL extends those capabilities into the clinical and translational domain, giving life science teams a continuous intelligence layer that spans the full spectrum of drug development, from early discovery through commercialisation.
hVIVO secures Decoy Therapeutics consultancy contract for antiviral development
Rallybio and Avenzo Therapeutics announce merger agreement and USD215m financing
IBA launches Cyclone iKure for industrial-scale Astatine-211 production
Avacta reports encouraging early efficacy signals for AVA6000 in salivary gland cancer at ASCO 2026
TiumBio presents Phase 2a interim data for Tosposertib plus pembrolizumab at ASCO 2026
ImmVira reports 100% CRR at 9 months in bladder carcinoma in situ with MVR-T3011
CARsgen presents long-term satri-cel follow-up results at 2026 ASCO Annual Meeting